全球桑格测序市场 – 行业趋势和 2030 年预测

桑格测序市场分析和规模

近年来，桑格测序因其在获取高质量 DNA 测序数据方面的准确性和可靠性而闻名。然而，桑格测序通常在可同时处理的样本数量方面受到限制。此外，桑格测序能够准确地对特定基因或感兴趣的区域进行测序，在诊断测试、识别致病突变和监测治疗反应方面发挥着至关重要的作用。临床基因组学的日益普及为桑格测序市场提供了机会。不过，获得基于桑格测序的测试的监管批准和报销范围可能具有挑战性，需要时间和资源来应对监管环境，这对市场的增长是一个挑战。

Data Bridge Market Research 分析，桑格测序市场规模在 2022 年为 227.52 亿美元，到 2030 年可能达到 88.464 亿美元，预计在预测期内的复合年增长率为 18.50%。由于对患者更好的诊断和检测方法的需求不断增长，“诊断”在桑格测序市场的应用领域中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

报告范围和市场细分

市场定义

Sanger DNA 测序技术依赖于 DNA 聚合酶在体外 DNA 复制过程中随机插入链终止双脱氧核苷酸，并使用电泳。然而，对于规模较小的项目和验证深度测序的结果，Sanger 方法仍然被广泛使用。它仍然可以创建超过 500 个核苷酸的 DNA 序列读数，并保持约 99.99% 的准确度，这使其比短读测序方法（如 Illumina）更具优势。

全球桑格测序市场动态

驱动程序

• 技术进步

桑格测序服务市场因测序方法技术发展、桑格测序优势及基因组图谱绘制计划增多而不断扩大，此外，测序应用及研发支出增加也助长了市场扩张。

• 研究与开发（R&D）活动

供应商对中国、印度和东南亚等发展中经济体的关注度不断提高，预计将推动市场扩张。随着研发支出的增加和桑格测序应用的蓬勃发展，预计市场将在不久的将来经历显著增长。

• 遗传疾病增多

基因检测对脊椎动物和植物的应用越来越广泛，影响市场增长的其他因素包括遗传疾病和定制药物的患病率和熟悉程度的提高。

机会

• 基因组学研究与开发

基因组学领域不断发展，癌症基因组学、罕见遗传疾病和传染病等领域的研究和开发工作不断开展。桑格测序是研究人员验证和确认通过下一代测序技术发现的遗传变异的宝贵工具。研发活动对桑格测序的需求为市场增长提供了机会。

• 个性化医疗需求日益增长

With advancements in genomic research and personalized medicine, there is a growing need for accurate and reliable genetic sequencing technologies like Sanger sequencing. This market opportunity arises from the increasing demand for genomic testing to guide personalized treatment plans for various diseases.

Restraints/Challenges

• Competition from next-generation sequencing (NGS) technologies

NGS technologies have revolutionized genetic sequencing by enabling high-throughput sequencing of entire genomes or exomes at a lower cost per base. As a result, the Sanger sequencing market faces competition from NGS platforms, which offer broader applications and higher throughput capabilities.

• Targeted sequencing limitations

Sanger sequencing is well-suited for targeted sequencing of specific genes or regions of interest. However, it may not be as suitable for whole-genome or exome sequencing due to its limited throughput and higher cost per base. This can restrict its application in certain research or clinical settings.

This Sanger sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Sanger Sequencing market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In June 2020, The FDA recently granted Illumina the Emergency Use Authorization (EUA) for its COVIDSeq Test, which is designed to sequence the entire genome of the brand-new SARS-CoV-2 virus. This test can handle more than 3,000 samples with the use of Illumina's high-throughput NovaSeq 6000 technology, and findings are available in 24 hours.

Global Sanger Sequencing Market Scope

The Sanger sequencing market is segmented on the basis of application, sequencing, laboratory, research, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Diagnostics
• Biomarkers and Cancer
• Reproductive Health
• Personalized Medicine
• Forensics
• Others

Sequencing

• Shotgun Sequencing
• Targeted Gene Sequencing
• Others

Laboratory

• Wet Labs
• Dry Labs

 Research

• In-House
• Outsourced

 End Use

• Academic
• Government Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Hospitals
• Clinics

Global Sanger Sequencing Market Regional Analysis/Insights

The global Sanger sequencing market is analyzed and market size insights and trends are provided by country, application, sequencing, laboratory, research, and end use as referenced above.

The countries covered in the Sanger Sequencing market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

North America is expected to dominate the Sanger sequencing market because of the rising number of geriatric population and innovative medical technology adoption.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to an expansion in research and development expenditure and a rise in the utilization of Sanger sequencing.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Sanger sequencing market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Sanger sequencing market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Sanger sequencing market.

Competitive Landscape and Sanger Sequencing  Market Share Analysis

The Sanger sequencing market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the Sanger sequencing market.

Some of the major players operating in the Sanger Sequencing market are:

• Thermo Fisher Scientific Inc (U.S.)
• Source BioScience (U.K.)
• GenScript (U.S.)
• LGC Limited (U.K.)
• CeMIA (U.S.),
• Quintara Biosciences (U.S.)
• GenHunter Corporation (U.S.)
• GENEWIZ（美国）、Nucleics（英国）
• SciGenom Labs Pvt. Ltd（印度）
• Microsynth AG（瑞士）
• Eurofins Scientific（卢森堡）
• LGC 有限公司 (英国)
• Fasteris SA（瑞士）
• StarSEQ GmbH（德国）

SKU-52733